Social Media Influencers Driving Unofficial Market for Unapproved Slimming Medication
An underground market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.
Experimental Drug Gaining Traction Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are encouraged to contact these accounts privately for source information, while also obtaining promotional offers.
Active Trade on Messaging Platforms
Additionally, a flourishing market exists on messaging services, where groups with numerous of members share “before and after” images, administration instructions and assertions of rapid British shipping. Sellers market the substance there before directing customers to WhatsApp for transactions.
Understanding The Experimental Drug
Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.
Medical Professionals Voice Concerns
Nevertheless, doctors and chemists have cautions that the sale of what remains an unapproved drug in the UK is worrisome and could result in users administering substances of uncertain source.
Several experts said the popularity for the experimental drug could be linked to the rising cost of licensed slimming treatments such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the British medical regulations.
Several influencers try to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still breach pharmaceutical, advertising, and consumer regulations, risking penalties, legal action or prison.
Platform Reaction and Content Removal
According to the social media company, the platform has taken down violative material and prohibited related hashtags and search suggestions. The company said it was committed to keeping the service secure and allocating resources in strengthening enforcement strategies.
Online Trading Operations
Research also found groups with up to 9,000 members marketing retatrutide using the platform's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays channels with thousands of users, filled with images of slimming results, glowing reviews and step-by-step guides for mixing or administering at home.
After moments of entering one community, a vendor posted contact information, where most transactions take place. The vendor sent an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None inquired about body mass, health issues or previous experience.
Product Details and Costs
Within these communities, messages show black plastic packages with postal service labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at home with purified liquid, or pre-filled injectors usually priced at £160 for 20 milligrams. When questioned how much time a pen should last, vendors give conflicting answers varying between a several days to “depends on your body”.
Platform Oversight and Security Measures
A representative for the messaging service said it regularly monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are injecting substances they can’t verify. Although the research behind retatrutide is valid, these online products may not include what they advertise,” stated a pharmacy expert, the head of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor linked the increase in interest to recent cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.
Her team has previously encountered patients injured by self-injection from unverified sources. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your well-being,” stated Wyllie. “These materials could be contaminated or improperly measured.”
Manufacturer Statement
A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company investigational product not yet approved … may expose patients to possibly significant health risks”.